El-Nile for Pharmaceuticals witnesses 30.6% lower profits in H1 FY2023/24

Updated 2/2/2025 1:33:00 PM
El-Nile for Pharmaceuticals witnesses 30.6% lower profits in H1 FY2023/24

Arab Finance: El-Nile Company for Pharmaceuticals and Chemical Industries (NIPH) logged 30.6% year-on-year (YoY) lower net profits after tax in the first half (H1) of fiscal year (FY) 2024/25, according to the financial results released on February 2nd.

The net profits plummeted to EGP 66.67 million from EGP 96.02 million in H1 FY2023/24.

Sales shrank by 22.3% YoY to EGP 595.98 million during the period from July to December 2024, versus EGP 766.66 million.

In FY 2023/24, the company’s net profits after tax dropped by 24.3% to EGP 90.226 million from EGP 119.213 million in FY2022/23.

Related News